Impact of respiratory virus molecular testing on antibiotic utilization in community-acquired pneumonia

American Journal of Infection Control

Volumn 45, Issue 12, 2017, Pages 1396-1398

  Blatt, Stephen P ^a   Yultyev, Aleksandr ^a   Huang, Miao ^a   Friedstrom, Scott ^a   Steinbrunner, Jennifer ^b  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b TriHealth   (United States)

Author keywords

Antibiotic stewardship; Community acquired pneumonia; Respiratory virus molecular test

Indexed keywords

ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; CREATININE; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; AGED; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL PNEUMONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CREATININE BLOOD LEVEL; DRUG UTILIZATION; FEMALE; HUMAN; HYPOKALEMIA; HYPOXIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; NONHUMAN; OXYGEN SATURATION; POLYMERASE CHAIN REACTION; RESPIRATORY VIRUS; RETROSPECTIVE STUDY; SEPSIS; THORAX RADIOGRAPHY; VIRUS PNEUMONIA; ANTIMICROBIAL STEWARDSHIP; CLINICAL TRIAL; COMMUNITY ACQUIRED INFECTION; GENETICS; ISOLATION AND PURIFICATION; VIROLOGY; VIRUS;

AGED; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL STEWARDSHIP; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; VIRUSES;

EID: 85028595379     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2017.07.019     Document Type: Article

References (10)

1. Minino, A.M., Murphy, S.L., Xu, J., Kochanek, K.D., Deaths: final data for 2008. Natl Vital Stat Rep 59 (2011), 1–126.
2. Jennings, L.C., Anderson, T.P., Beynon, K.A., Chua, A., Laing, R.T., Werno, A.M., et al. Incidence and characteristics of viral community acquired pneumonia in adults. Thorax 63 (2008), 42–48.
3. Johansson, N., Kalin, M., Tiveljung-Lindell, A., Giske, C.G., Hedlund, J., Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 50 (2010), 202–209.
4. Oosterheert, J.J., van Loon, A.M., Schuurman, R., Hoepelman, A.I., Hak, E., Thijsen, S., et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 41 (2005), 1438–1444.
5. Falsey, A.R., Murata, Y., Walsh, E.E., Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 167 (2007), 354–360.
6. Shiley, K.T., Lautenbach, E., Lee, I., The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?. Infect Control Hosp Epidemiol 31 (2010), 117–1183.
7. Rahal, J.J., Urban, C., Horn, D., Freeman, K., Segal-Maurer, S., Maurer, J., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280 (1998), 1233–1237.
8. Muller, A.A., Mauny, F., Bertin, M., Cornette, C., Lopez-Lozano, J.M., Viel, J.F., et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 36 (2003), 971–978.
9. Falsey, A.R., Becker, K.L., Swinburne, A.J., Nylen, E.S., Formica, M.A., Hennessey, P.A., et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 208 (2013), 432–441.
10. Schuetz, P., Müller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev(9), 2012 CD007498.